livzon pharmaceutical grou-a (000513) Snapshot

livzon pharmaceutical grou-a (000513) Details

Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of various pharmaceutical products. The company’s products include bismuth potassium citrate granules series, shenqifuzheng injection, antivirus granules, urofollitropin for injection, cefodizime sodium for injection, voriconazole, valaciclovir hydrochloride tablets, qianliean suppository, divitamins notonginseng and cinarizine, factive film-coated tablets, and ilaprazole, as well as leuprorelin acetate microspheres and mouse nerve growth factor for injection, and other medical preparations. It also offers mevastatin, pravachol, mycophenolic acid, ceftriaxone, cefuroxime, cefodizime, phenylalanine, vancomycin, and salinomycin; kouyanning infusion, xueshuantong, live bifidobacterium preparation, cefoperazone sodium and sulbactam sodium for injection, colistin sulfate, kanamycin monosulf, etc; and bio-chemical raw material medicines, including menotrophin and chorionic gonadotrophin for injection, etc. In addition, the company provides raw-material drugs, including chemical drugs, biochemical drugs, micro-ecological preparations, Chinese patent drugs, and chemical raw materials, as well as diagnostic reagents, such as chlamydia trachomatis antigen diagnostic reagent kit and HIV antibody diagnostic reagent kits. Further, it manufactures APIs, such as fermented antibiotics, sterile cephalosporins, and hypolipemic statins. The company sells its products through agents, hospitals, pharmacies, and business partners the People’s Republic of China and internationally. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, the People’s Republic of China.

livzon pharmaceutical grou-a (000513) Top Compensated Officers